Patients with diabetes Tadalafil exposure (AUC) in patients with diabetes was approximately 19% lower than the AUC value for healthy subjects.
Diabeediga patsiendid Tadalafiili AUC oli suhkurdiabeeti põdevatel patsientidel ligikaudu 19% madalam kui tervetel.